DarioHealth Corp Financials

DRIO Stock  USD 0.71  0.01  1.39%   
Based on the analysis of DarioHealth Corp's profitability, liquidity, and operating efficiency, DarioHealth Corp may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter. At this time, DarioHealth Corp's Net Receivables is very stable compared to the past year. As of the 21st of March 2025, Common Stock Total Equity is likely to grow to 4,456, while Other Current Liabilities is likely to drop about 3.2 M. Key indicators impacting DarioHealth Corp's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Current Ratio2.191.7214
Significantly Up
Pretty Stable
Investors should never underestimate DarioHealth Corp's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor DarioHealth Corp's cash flow, debt, and profitability to make informed and accurate decisions about investing in DarioHealth Corp.

Net Income

43.03 Million

  
Understanding current and past DarioHealth Corp Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of DarioHealth Corp's financial statements are interrelated, with each one affecting the others. For example, an increase in DarioHealth Corp's assets may result in an increase in income on the income statement.

DarioHealth Corp Stock Summary

DarioHealth Corp competes with Burning Rock, Neuronetics, Sera Prognostics, Fonar, and Biodesix. DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York. Dario Health operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 200 people.
Specialization
Health Care, Health Care Equipment & Services
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS23725P2092
CUSIP23725P209 23725P100 50544T302 50544T203
LocationIsrael
Business Address322 W 57th
SectorHealth Care Technology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.dariohealth.com
Phone972 477 0637 7
CurrencyUSD - US Dollar

DarioHealth Corp Key Financial Ratios

DarioHealth Corp Key Balance Sheet Accounts

202020212022202320242025 (projected)
Total Assets35.4M100.8M119.2M96.4M118.9M124.8M
Other Current Liab2.7M7.5M6.6M6.3M6.1M3.2M
Net Debt(28.1M)(35.5M)(21.3M)(7.3M)2.4M2.5M
Retained Earnings(143.2M)(222.0M)(285.9M)(349.4M)(390.3M)(370.8M)
Accounts Payable2.5M5.1M2.3M1.1M3.0M2.1M
Cash28.6M35.8M49.4M36.8M27.8M18.8M
Net Receivables1.7M1.8M6.4M3.6M4.8M5.0M
Other Current Assets1.5M1.8M1.8M1.8M175K166.3K
Total Liab7.3M15.2M39.2M38.2M46.9M49.2M
Total Current Assets34.1M45.6M65.5M47.3M28.6M23.5M
Net Tangible Assets18.9M28.4M31.4M28.4M32.7M34.3M
Other Assets205K77K117K(238K)11.9M12.5M
Capital Surpluse129.0M171.4M307.6M365.8M420.7M441.8M
Inventory2.3M6.2M8.0M5.1M4.8M3.2M
Net Invested Capital28.2M85.5M106.9M86.7M100.9M60.5M
Net Working Capital27.1M31.2M46.2M34.8M23.9M26.4M

DarioHealth Corp Key Income Statement Accounts

202020212022202320242025 (projected)
Interest Expense49K84K1.9M645K741.8K778.8K
Operating Income(29.9M)(76.5M)(56.8M)(56.2M)(57.7M)(54.9M)
Ebit(30.2M)(76.6M)(60.6M)(59.4M)(53.4M)(50.8M)
Research Development4.4M17.2M19.6M20.2M24.2M25.4M
Ebitda(29.7M)(73.1M)(56.8M)(54.4M)(57.7M)(54.9M)
Income Before Tax(29.4M)(76.7M)(62.2M)(59.4M)41.0M43.0M
Net Income(29.0M)(76.8M)(62.2M)(59.4M)41.0M43.0M
Income Tax Expense(458K)32K4K64K41.0M43.0M
Total Revenue7.6M20.5M27.7M20.4M27.0M28.4M
Gross Profit2.5M4.0M9.7M6.0M13.3M13.9M
Cost Of Revenue5.1M16.6M18.0M14.4M13.8M9.4M
Interest Income61K44K506K1.7M1.1M623.7K
Net Interest Income12K(40K)(2.2M)(820K)1.0M1.1M

DarioHealth Corp Key Cash Accounts

202020212022202320242025 (projected)
Change In Cash8.2M7.2M13.5M(12.7M)(9.0M)(8.6M)
Free Cash Flow(17.9M)(50.7M)(48.4M)(31.0M)(38.7M)(36.8M)
Depreciation190K3.3M4.7M5.0M7.4M7.8M
Other Non Cash Items12.7M637K3.6M288K(16.6M)(15.7M)
Capital Expenditures118K261K573K584K138K131.1K
Net Income(29.4M)(76.8M)(62.2M)(59.4M)(42.7M)(44.9M)
End Period Cash Flow28.7M35.9M49.5M36.8M27.8M18.8M
Change To Inventory(879K)(2.2M)(1.7M)2.9M308K323.4K
Investments(1.5M)(400K)(573K)(523K)(8.9M)(8.5M)
Change To Netincome2.3M11.1M25.0M17.0M19.5M20.5M
Change Receivables(504K)548K(351K)(5.1M)(4.6M)(4.4M)

DarioHealth Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining DarioHealth Corp's current stock value. Our valuation model uses many indicators to compare DarioHealth Corp value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across DarioHealth Corp competition to find correlations between indicators driving DarioHealth Corp's intrinsic value. More Info.
DarioHealth Corp is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, DarioHealth Corp's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the DarioHealth Corp's earnings, one of the primary drivers of an investment's value.

DarioHealth Corp Systematic Risk

DarioHealth Corp's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. DarioHealth Corp volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on DarioHealth Corp correlated with the market. If Beta is less than 0 DarioHealth Corp generally moves in the opposite direction as compared to the market. If DarioHealth Corp Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one DarioHealth Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of DarioHealth Corp is generally in the same direction as the market. If Beta > 1 DarioHealth Corp moves generally in the same direction as, but more than the movement of the benchmark.

DarioHealth Corp Thematic Clasifications

DarioHealth Corp is part of Medical Equipment investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Medical Equipment industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
Medical EquipmentView
This theme covers USA Equities from Medical Equipment industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
Today, most investors in DarioHealth Corp Stock are looking for potential investment opportunities by analyzing not only static indicators but also various DarioHealth Corp's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of DarioHealth Corp growth as a starting point in their analysis.

Price Earnings To Growth Ratio

(0.009302)

At this time, DarioHealth Corp's Price Earnings To Growth Ratio is very stable compared to the past year.

DarioHealth Corp March 21, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of DarioHealth Corp help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of DarioHealth Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of DarioHealth Corp based on widely used predictive technical indicators. In general, we focus on analyzing DarioHealth Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build DarioHealth Corp's daily price indicators and compare them against related drivers.
When determining whether DarioHealth Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of DarioHealth Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dariohealth Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dariohealth Corp Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DarioHealth Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
To learn how to invest in DarioHealth Stock, please use our How to Invest in DarioHealth Corp guide.
You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DarioHealth Corp. If investors know DarioHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DarioHealth Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.61)
Revenue Per Share
0.551
Quarterly Revenue Growth
1.103
Return On Assets
(0.33)
Return On Equity
(0.66)
The market value of DarioHealth Corp is measured differently than its book value, which is the value of DarioHealth that is recorded on the company's balance sheet. Investors also form their own opinion of DarioHealth Corp's value that differs from its market value or its book value, called intrinsic value, which is DarioHealth Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DarioHealth Corp's market value can be influenced by many factors that don't directly affect DarioHealth Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DarioHealth Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if DarioHealth Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DarioHealth Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.